CHONDROSARCOMA, GRADE 3

Clinical trials for CHONDROSARCOMA, GRADE 3 explained in plain language.

Never miss a new study

Get alerted when new CHONDROSARCOMA, GRADE 3 trials appear

Sign up with your email to follow new studies for CHONDROSARCOMA, GRADE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Targeted drug trial offers hope for Tough-to-Treat bone cancer

Disease control Ongoing

This study is testing whether the drug AG-120 is safe and effective for people with advanced or returning chondrosarcoma, a type of bone cancer, that has a specific genetic change called an IDH1 mutation. The main goal is to see if the drug can stop the cancer from growing. The t…

Matched conditions: CHONDROSARCOMA, GRADE 3

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

CHONDROSARCOMA, GRADE 3

Get alerted when new CHONDROSARCOMA, GRADE 3 trials appear

Targeted drug trial offers hope for Tough-to-Treat bone cancer